ストックスクリーナーアプリを入手
7.64
3.54%
-0.28
アフターアワーズ：
7.13
-0.51
-6.68%
前日終値:
$7.92
開ける：
$7.43
24時間の取引高:
6,881
Relative Volume:
0.47
時価総額：
$3.91M
収益：
-
当期純損益:
$-8.26M
株価収益率:
-0.1425
EPS:
-53.609
ネットキャッシュフロー:
$-12.17M
1週間 パフォーマンス:
+9.30%
1か月 パフォーマンス:
-28.64%
6か月 パフォーマンス:
-11.10%
1年 パフォーマンス:
-95.78%
1日の値動き範囲:
$7.30
$7.96
1週間の範囲:
$6.53
$10.95
52週間の値動き範囲:
$5.1255
$202.22
Gri Bio Inc Stock (GRI) Company Profile
GRI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
7.64 | 3.91M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | H.C. Wainwright | Buy |
Gri Bio Inc (GRI) 最新ニュース
Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn
GRI Bio announces 1-for-17 reverse stock split to regain Nasdaq compliance - MSN
GRI Bio Stock Set to Reverse Split on Monday, February 24th (NASDAQ:GRI) - Defense World
GRI Bio Announces Reverse Stock Split - GlobeNewswire
Can GRI Bio's 17:1 Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire
Vstock Transfer Announces Sponsorship of the Centri Capital Conference at Nasdaq - The Manila Times
Virtual Investor “Top 5 for ’25” Conference Hosted by JTC Now Available On-Demand - The State
GRI Bio, Inc. Highlights Key Investment Reasons at Virtual Investor Conference - Nasdaq
Inside GRI Bio's Ambitious NKT Cell Strategy: Can This Biotech Reshape Inflammatory Disease Treatment? - StockTitan
GRI Bio approves reverse stock split, stockholders vote in favor - MSN
MediWound stock climbs 4% on Phase 3 study initiation - MSN
GMR agree deal for Southern Brave to conclude Hundred sell-off - MSN
GRI Bio approves reverse stock split, stockholders vote in favor By Investing.com - Investing.com Australia
Cargill to take full control of Brazil's SJC Bioenergia - MSN
Analyzing the Price-to-Earnings Ratio of GRI Bio Inc (GRI) - The News Heater
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BriaCell Therapeutics stock rises on positive clinical trial results - MSN
Phibro Animal Health (NASDAQ:PAHC) and GRI Bio (NASDAQ:GRI) Critical Review - Defense World
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire
SRIVARU Holding faces trading suspension after nasdaq delisting determination - MSN
JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024 - ACCESS Newswire
IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register
Windtree Therapeutics Appoints Leanne Kelly to Board of Directors and Audit Committee - Defense World
Windtree Therapeutics Appoints Leanne Kelly to Board, Advances New Growth Strategy - MyChesCo
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - The Manila Times
Windtree Therapeutics Strengthens Board with Biotech Finance Veteran Leanne Kelly - StockTitan
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: HSDT, PBM, MTEM, APTO... - RTTNews
The GRI Marketing Group Joins SDL to Accelerate North America CX Growth Strategy - Yahoo Finance
Short Interest in GRI Bio, Inc. (NASDAQ:GRI) Increases By 155.5% - Defense World
FLYHT Aerospace Solutions Ltd. (OTCMKTS:FLYLF) Sees Significant Growth in Short Interest - Defense World
Viracta stock falls on strategic review (VIRX:NASDAQ) - Seeking Alpha
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and - EIN News
GRI Bio Announces European Patent Office Issued a Decision - GlobeNewswire
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds - GlobeNewswire Inc.
Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha
GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World
GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register
Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register
Pre-market Movers: SXTC, STIM, BIOA, UPC... - RTTNews
GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire
GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan
GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India
GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire
GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan
GRI Bio files to sell 1.58M shares of common stock for holders - MSN
SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow
GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire
GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan
Gri Bio Inc (GRI) 財務データ
収益
当期純利益
現金流量
EPS
6.45%
1.23%
大文字化:
|
ボリューム (24 時間):